Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

that is associated with this bacterial infection. Clostridioides difficile (previously known as Clostridium difficile) is a highly contagious organism that primarily impacts people over age 65 ...

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple ...

For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes.

This indicator covers the incidence of healthcare associated infections from Clostridium difficile (C. diff). It measures outcomes that reflect the quality of care or processes linked by evidence to ...

Antibiotic treatment alters the intestinal microbiota resulting in hard-to-treat Clostridium difficile infections C. difficile produces toxins that damage intestinal cells and cause inflammation, ...

Clostridium Difficile Infections companies working in market are Pfizer, Valneva, GlaxoSmithKline, Summit Therapeutics, MGB Biopharma, Acurx Pharmaceuticals. LAS ...

Like healthcare systems all over the world there are times when things go tragically wrong. We all understand that healthcare ...

PF-06425090 is under clinical development by Pfizer and currently in Phase III for Clostridioides difficile Infections (Clostridium difficile Associated Disease). According to GlobalData, Phase III ...